| Document Date: 2009-05-13 08:08:26
Open Document File Size: 793,49 KBShare Result on Facebook
Continent North America / Europe / / Country United States / / Currency pence / / IndustryTerm maltitol solution / chemical name / saturable and stereoselective neuronal binding site / messenger systems / mg/mL oral solution / food / / MedicalCondition human complex partial seizures / partial seizures / single seizures / seizures / weekly seizure / refractory partial onset seizures / partial seizure / seizure / Years Of Age With Juvenile Myoclonic Epilepsy / partial onset seizure / focal seizures / epilepsy / least two partial onset seizures / end stage renal disease / juvenile myoclonic epilepsy / myoclonic seizures / weekly partial seizure / human epilepsy / partial onset seizures / epileptic seizures / / MedicalTreatment adjunctive therapy / hemodialysis / dialysis / / Organization DOSAGE AND ADMINISTRATION / PRECAUTIONS / / Position Major / messenger / / Product probenecid / topiramate / phenytoin / talc / KEPPRA / digoxin / lamotrigine / valproic acid / carbamazepine / polyethylene glycol / Levetiracetam tablets / glycine / Rx / / Technology Pharmacokinetics / UDP / dialysis / /
SocialTag |
KEPPRA® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg tablets 100 mg/mL oral solution Rx only